Metabolomics and network pharmacology reveal partial insights into the hypolipidemic mechanisms of ferulic acid in a dyslipidemia mouse model
Through the synergy of network pharmacology and metabolomics, this study provides insights into how FA regulates endogenous metabolites, underscoring its promise as a treatment for hyperlipidemia.
Authors
- Xiaoli Bi (ORCID: https://orcid.org/0000-0002-8800-4705)
- Sumei Li (ORCID: https://orcid.org/0000-0002-4793-3161)
- Yanchang Liu (ORCID: https://orcid.org/0000-0003-1464-1960)
- Yangxue Li (ORCID: https://orcid.org/0000-0002-9907-2973)
- Guanlin Xiao (ORCID: https://orcid.org/0000-0002-5912-8434)
- Zhihao Zeng (ORCID: https://orcid.org/0000-0002-7117-9496)
- Minshan Wu
- Dezheng Jia
- Xingqin Wei
- Canhui Xie
- Guangying Wu
Institutions
- Guangzhou University of Chinese Medicine (CN)
- Guangdong Provincial Hospital of Traditional Chinese Medicine (CN)
- Traditional Chinese Medicine Bureau of Guangdong Province (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-09-20
- DOI
- https://doi.org/10.3389/fphar.2024.1466114
- Citations
- 3
- Primary Topic
- Metabolomics and Mass Spectrometry Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.70
Funders
- Basic and Applied Basic Research Foundation of Guangdong Province